Practical Application and Evaluation of Fortimel in Oncology Patients
NCT06698783 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2000
Last updated 2024-11-21
Summary
This study is a multicenter registry and is a prospective, observational, real-world study.
Subjects were selected by clinicians for oral ONS nutritional intervention according to the actual clinical situation and the patient's wishes, and the observation period was 4 weeks.
Subjects will receive a ready-to-drink marketed formula for special medical purposes with 4 flavors for free Food liquid preparation (Nengli Yijia, Nutricia in the Netherlands) for rounds of nutritional intervention, providing
1 flavor per week, 1-2 bottles per day, 4 flavors for a total of 28 days. The basic nutritional status and quality of life of patients were mainly evaluated at multiple time nodes before and after nutritional intervention.
In order to improve the compliance of subjects, the all-round guardian platform (hereinafter referred to as the platform) by the China Initial Insurance Foundation was used during the intervention period to provide basic nutrition supervision, education and dietary guidance in routine nutrition support.
Recruitment method: Convenient sampling method is adopted, from the beginning of recruitment to the target sample size.
Follow-up period: After the start of the intervention, it will be carried out according to the plan of the follow-up task to the end of the intervention on the 28th day. The last telephone follow-up visit will complete on the 60th day after the end of the pre-end.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Fortimel
In this study, patients will be provided with ONS preparation (4 kinds of ready-to-drink special medical food) free of charge during the treatment period. Doctors will provide patients with different flavor nutritional preparations on a weekly basis, 2 bottles per day for patients with 1 flavor per week, and 14 bottles per day for each of 4 flavors at the recommended dosage of 400 kcal per day 28 days
Sponsors & Collaborators
-
Peking Union Medical College Hospital
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-12-01
- Primary Completion
- 2024-12-31
- Completion
- 2025-01-31
Countries
- China
Study Locations
More Related Trials
-
Early and Whole Course Nutritional Support by Nutren® Optimum During IMRT for Nasopharyngeal Carcinoma
NCT03344068 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effect of an Oral Supplement on the Total Energy and Protein Intake of Head and Neck Cancer Patients in the Last 2 Weeks of Radiation Therapy
NCT00375700 ·Status: WITHDRAWN ·Phase: NA
-
Oral Enteral Nutrition in Delayed Onset Radiotherapy-related Swallowing Disorder in Nasopharyngeal Carcinoma
NCT06301763 ·Status: COMPLETED ·Phase: NA
-
Food Supplements Based on Nettle and Peppermint to Control Signs and Symptoms Induced by Cancer Therapies
NCT04474951 ·Status: UNKNOWN ·Phase: NA
-
Application and Validation of a Smartphone-based Deep Learning System for Oral Potentially Malignant Disorders and Oral Cancer Screening
NCT06862414 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy
NCT05892354 ·Status: RECRUITING ·Phase: NA
-
Sensory Evaluation of Oral Nutrition Supplements in Patients at Risk for Mucositis Undergoing Cancer Treatment
NCT03228147 ·Status: COMPLETED ·Phase: NA
-
Upfront Surgery Vs Induction Chemotherapy Followed By Surgery In Oral Cancers:
NCT06737822 ·Status: RECRUITING ·Phase: PHASE3
-
Effect of Nutritional Management on RIOM in Patients With Advanced Head and Neck Cancer
NCT05721885 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effect of Active Nutritional Support On Quality Of Life In Patients With Head And Neck Cancer Receiving Radiotherapy
NCT06477341 ·Status: COMPLETED ·Phase: NA
-
Melatonin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response in Locally Advanced Oral Squamous Cell Carcinoma
NCT04137627 ·Status: COMPLETED ·Phase: PHASE3
-
Improved Oral Health in Head and Neck Cancer Survivors
NCT07173270 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
PROSpECT-PRIOR-2-CHEMO: PRIOR Dental Intervention Before Chemo to Reduce Chemotherapy Complications
NCT06450821 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prevalence of Long-term Dental Effects of Chemotherapy in Childhood Cancer Survivors Diagnosed With Cancer Before the Age of 10
NCT06517927 ·Status: RECRUITING ·Phase: NA
-
Efficacy of an Oral Immunomodulatory Nutrient on Survival During Postoperative Concomitant Chemoradiotherapy in Head and Neck Cancer
NCT04001543 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effects of Oral L-Glutamine in Head and Neck Cancer Patients During Radiotherapy
NCT03015077 ·Status: COMPLETED ·Phase: NA
-
The Characterisation of RT Caries.
NCT03397823 ·Status: COMPLETED
-
A Real-world Observational Study of a Mucosal Contouring Method for Radiation-induced Oropharyngeal Mucositis
NCT06308328 ·Status: RECRUITING
-
ChemoRT With and Without Dental Stent for Taste Protection in NPC Patients
NCT06733948 ·Status: RECRUITING ·Phase: PHASE2
-
A Trial Assessing Chemo Mouthpiece Device With Best Supportive Care for Symptoms of Chemotherapy-Induced Oral Mucositis
NCT04595838 ·Status: COMPLETED ·Phase: NA
-
The Effect of GM-CSF to Preventing Oral Mucositis for Patients With Nasopharyngeal Carcinoma Receiving Radiotherapy
NCT06472739 ·Status: RECRUITING ·Phase: PHASE2
-
Effects for Oral Mucositis Care During Chemoradiotherapy in Cancer Patients: Evaluation of the Bee Products
NCT05625841 ·Status: UNKNOWN ·Phase: NA
-
A Trial Looking at Treating Dry Mouth After Radiotherapy for Head and Neck Cancer
NCT02941276 ·Status: COMPLETED ·Phase: NA
-
Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral Cancer Cancer.
NCT03638622 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
NCT06532279 ·Status: RECRUITING ·Phase: PHASE2